The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
Read more
The third chapter of a nine-part webcomic, Planet DIVOC-91, featuring articles and art by young adults about COVID-19, was recently published.
Read more
Manchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan
Read more
Manchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.
Read more
Manchester’s world-class health innovation campus – a joint venture between Manchester University NHS Foundation Trust and Manchester Science Partnerships (MSP) – takes a step forward.
Read more
A research study evaluating the presence of COVID-19 antibodies in children and young people is taking place at ourTrust.
Read more
A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.
Read more
Many MFT staff members are involving their children in our vitally important COVID-19 research, with some of them sharing their experiences.
Read more
